Vogt-Koyanagi-Harada Syndrome
Authors:
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis in Current Eye Research
- Vol. 33 (7) , 517-523
Abstract
Vogt-Koyanagi-Harada syndrome is a bilateral, chronic, diffuse granulomatous panuveitis frequently associated with neurological, auditory, and integumentary manifestations. It is also one of the most common forms of uveitis among pigmented races including Chinese patients. This article reviews the current developments of Vogt-Koyanagi-Harada syndrome, including epidemiology, etiology, clinical features, observational techniques, genetics, treatment, and prognosis. Increasing reports have been published to describe the clinical features of Vogt-Koyanagi-Harada syndrome in various ethnic populations from different parts of the world. In spite of tremendous progress in laboratory and clinical research, the etiology of Vogt-Koyanagi-Harada syndrome is still not completely known. Numerous studies indicate an autoimmune nature for this disease. A recent study has shown that Th17, a new subset of T cell, plays an important role in the initiation and maintenance of this disease. Early and aggressive systemic corticosteroids are still the mainstay of initial therapy for Vogt-Koyanagi-Harada syndrome. However, nonsteroid immunomodulatory therapy, including cyclosporine, chlorambucil, cyclophosphamide, and azathioprine have brought out encouraging results. Improved visual outcomes in patients with Vogt-Koyanagi-Harada syndrome in recent years have been reported when compared with decades ago, presumably due to the more aggressive use of immunosuppressive agents. Although the prognosis for VKH syndrome was greatly improved, future prospective, controlled, multi-center studies are needed to determine the optimal treatment regime for this disease. The IL17/23 pathway may provide a novel therapeutic target to control inflammation in VKH syndrome.Keywords
This publication has 64 references indexed in Scilit:
- Vogt–Koyanagi–Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and JapanInternational Ophthalmology, 2007
- Clinical Characteristics of Vogt–Koyanagi–Harada Syndrome in Chinese PatientsOphthalmology, 2007
- The spectrum of Vogt-Koyanagi-Harada disease in South IndiaInternational Ophthalmology, 2007
- Spectrum of Vogt-Koyanagi-Harada disease in SingaporeInternational Ophthalmology, 2006
- Vogt-Koyanagi-Harada Disease: Clinical OutcomesAmerican Journal of Ophthalmology, 2005
- Update on uveomeningoencephalitidesCurrent Opinion in Neurology, 2005
- Visual function in Vogt-Koyanagi-Harada patientsGraefe's Archive for Clinical and Experimental Ophthalmology, 2005
- Changing patterns of intraocular inflammatory disease in JapanOcular Immunology and Inflammation, 2003
- Analysis of 87 Cases with Vogt-Koyanagi-Harada DiseaseJapanese Journal of Ophthalmology, 2000
- Vogt-Koyanagi-Harada syndromeSurvey of Ophthalmology, 1995